Using Biosen to Improve D-Allulose Biosynthesis Through Growth-Coupled Evolutionary Pressure on Epimerases

Enzyme performance dictates D-allulose economics

Enzyme cost is often what decides whether D-allulose can compete in the sweetener market. This paper tackles that problem directly. It describes a new way to evolve ketose 3-epimerases (KEases) so they work faster and hold up better at commercial temperatures. The result is a variant called M42, with a 6.28-fold improvement in catalytic activity and a 2.5-fold longer half-life at 60 °C. That is the kind of jump that gets formulators’ attention.

Background: KEases and the bottleneck

D-allulose is a rare sugar with nearly no calories, but it does not occur in large quantities in nature. The most practical route to make it is enzymatic isomerization of D-fructose using KEases. Those enzymes are not ideal, though. Natural KEases tend to have low activity and poor thermostability. In a production environment, that means higher enzyme loading, longer reaction times, and more purification headaches.

Improving an enzyme is not just about random mutation. You need a way to find the rare beneficial variant among thousands of candidates. Traditional screening methods are slow and labor-intensive. This study offers a smarter selection system.

What the study did

The researchers developed a growth-coupled in vivo screening platform using a D-allulose-dependent biosensor named Biosen. The concept is elegant. When a bacterial cell produces D-allulose, the biosensor detects it and activates expression of a gene linked to cell growth. More D-allulose production means faster growth. That creates evolutionary pressure: only the best epimerase variants let their host cells outcompete the rest.

This approach converts an analytical problem into a growth advantage. Instead of measuring each mutant individually, the team simply let the cells select the winners. They used directed evolution to generate libraries of KEase variants, then put those libraries through the Biosen-based growth selection.

Key findings

The star variant, M42, came out of this selection with major gains.

Metric	Wild-type ADAE	Mutant M42
Catalytic activity	Reference level	6.28-fold higher
Half-life at 60 °C	Reference level	2.5-fold longer
D-Allulose yield from D-fructose in 3 h	Baseline	32.2%

The 32.2% conversion is practical, not just incremental. It shows that M42 can convert a meaningful portion of D-fructose into D-allulose in a short window. The improved thermostability matters just as much. Longer half-life at 60 °C means a reactor can run hotter, which typically improves substrate solubility and reduces viscosity. It also means less enzyme gets thrown away after each batch.

What this means for manufacturers

For ingredient buyers and production planners, the real takeaway is biocatalyst cost. A more active enzyme means you need less of it to achieve the same conversion. A more stable enzyme means it survives longer under process conditions. Both factors push down the enzyme cost per kilogram of D-allulose.

The growth-coupled platform also has implications beyond this one mutant. The Biosen-based selection can be adapted to evolve other KEases or to target additional traits like pH tolerance and substrate specificity. That gives enzyme suppliers a faster route to commercial-grade catalysts.

This is still research-stage work, not a ready-to-use commercial enzyme. But the strategy is clear. If a biosensor can link D-allulose production to growth, then the enzyme can be improved without repeated manual screening. That shortens development cycles significantly.

FAQ

What is growth-coupled screening? It links a desired product to cell survival or growth. In this case, D-allulose production triggers a biosensor that drives growth. Cells with better enzymes grow faster and dominate the culture.

Why does thermostability matter for D-allulose production? Higher temperature speeds up reactions and helps dissolve high fructose loads. An enzyme with a longer half-life at 60 °C can handle those conditions longer, which lowers enzyme usage and operating costs.

Is the M42 mutant ready for commercial food production? Not yet. It is a promising laboratory result that needs process-scale validation. But the performance gains make it a strong candidate for further development.

This paper gives formulators a good reason to watch the enzyme supply pipeline. Faster selection tools mean better catalysts arrive sooner. And when an epimerase can hit 32.2% conversion in three hours at 60 °C, the economics of D-allulose start to look a lot more attractive.